After purging its own candidates, Merck says it's ready to assist in Covid-19 vaccine production
Days after quashing high hopes of a late but reliable addition to the global Covid-19 vaccine menu, Merck is searching for a way back to the action.
Having pioneered important immunizations in public health emergencies over the decades — developing shots for mumps, chicken pox and more recently Ebola — Merck execs now say they are willing to open up their infrastructure in service of vaccines developed by biopharma rivals.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.